Trialant
Platform
Home
Studies
Other
Contact Us
Terms of Service
Privacy Policy
Toggle Sidebar
Studies
Study
JSON
Overview
Key facts that identify this study and show where it stands today.
Description
What the study is about and why it is being run, in the researchers' own words.
Conditions
The medical conditions and diseases this study investigates.
Interventions
The treatments and procedures being evaluated in this study.
Participation
Who can join this study and the criteria used to decide.
Design
How the study is designed and how its participant groups are organized.
Contacts
The people to reach with questions about this study or how to join it.
Locations
Where the study is run and whether each site is currently recruiting.
Collaborators
The organizations and people involved in this study.
Similar Studies
Other registered studies that closely resemble this one.
Workspace
Home
Studies
Collections
Views
Contact Us
Terms of Service
Privacy Policy
Sign up
NCT01086774
Evaluation of SYSTANE Ultra Lubricant Eye Drops
NCT00702377
Completed
Interventional
Not Applicable
Updated Feb 2, 2012
An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye
NCT01223040
Completed
Interventional
Not Applicable
Updated Apr 10, 2012
Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
NCT01417013
Withdrawn
Interventional
Not Applicable
Updated Feb 8, 2012
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726
Completed
Interventional
Not Applicable
Updated Jun 29, 2018
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
NCT01967147
Completed
Interventional
Not Applicable
Updated Mar 23, 2016
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
NCT00724412
Completed
Interventional
Phase 4
Updated Feb 2, 2012
Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects | NCT01086774 | Trialant
Save
Share
Completed
Interventional
Phase 4
Updated Feb 2, 2012
Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects
ClinicalTrials.gov ID
NCT01086774
Lead Sponsor
Alcon Research
INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
10
Actual
Last Update Posted
Feb 2, 2012
Estimated
Start Date
Jul 2010
Primary Completion Date
Nov 2010
Actual
Brief Summary
Evaluation of the optical effects of Systane Ultra
Dry Eye
Systane Ultra Lubricant Eye Drops
Ages Eligible for Study
Adult (18-64)
Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Age 18 years or more.
Subjects must have Tear Break Up Time (TBUT) < 5 seconds
Subjects must have a maximum blink interval (MBI) < 10 seconds
Subjects must be willing to comply with all study requirements.
Subjects must understand, sign and be given a copy of the written Informed Consent form.
Exclusion Criteria:
Subjects for whom both eyes do not meet all inclusion criteria and either eye meets exclusion criteria
Subjects who are pregnant, lactating or planning to be pregnant during the course of the study
Subjects with known sensitivity to planned study concomitant medications
Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation.
Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication
Primary Purpose
Treatment
Allocation
N/A
Interventional Model
Single Group Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
No locations
There are no locations for this study.
Lead Sponsor
Alcon Research
INDUSTRY